Effect of New Evidence on Antithrombotic Therapies in Atrial Fibrillation Patients Who Undergo Percutaneous Coronary Intervention in Alberta, Canada

BACKGROUND: Trials have addressed the combined use of direct oral anticoagulants (DOACs) and antiplatelets in atrial fibrillation (AF) patients undergoing percutaneous coronary intervention (PCI). These trials may have changed prescribing patterns. METHODS: This administrative audit of Albertans wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Eberhardt, Theresa E., Bungard, Tammy J., Graham, Michelle M., Picard, Michelle, Wang, Grace T., Ackman, Margaret L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039572/
https://www.ncbi.nlm.nih.gov/pubmed/35495861
http://dx.doi.org/10.1016/j.cjco.2021.12.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039572/
https://www.ncbi.nlm.nih.gov/pubmed/35495861
http://dx.doi.org/10.1016/j.cjco.2021.12.007

Ejemplares similares